SCHEMBL3595192

SCHEMBL3595192

COc1ccc(-n2c(C)nc(C(=O)Cc3ccnc(Cl)c3)c2C)cc1C(F)(F)F

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM5 P41594 5/20 0.44
PTGDR2 Q9Y5Y4 2/20 0.41
KCNH2 Q12809 2/20 0.39
ADRB3 P13945 1/20 0.39
TSPO P30536 1/20 0.39
TMEM97 Q5BJF2 1/20 0.39
SIGMAR1 Q99720 1/20 0.39
GPR35 Q9HC97 1/20 0.39
CNR1 P21554 2/20 0.36
CNR2 P34972 2/20 0.36
CSF1R P07333 3/20 0.36
CDK2 P24941 1/20 0.35
GSK3B P49841 1/20 0.35
GPR52 Q9Y2T5 1/20 0.35
NOTUM Q6P988 1/20 0.34
GCGR P47871 1/20 0.34
GAA P10253 1/20 0.34
MAPK1 P28482 1/20 0.34
KDR P35968 2/20 0.34
RET P07949 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3604477 0.78 GRM5 (0.42) GRM5PTGDR2KCNH2ADRB3TSPO
SCHEMBL3604478 0.78 GRM5 (0.42) GRM5PTGDR2KCNH2ADRB3TSPO
SCHEMBL3605776 0.78 MAPT (0.48) GRM5CNR1CNR2GAAMAPK1
SCHEMBL609393 0.75 GRM5 (0.68) GRM5PTGDR2KCNH2ADRB3TSPO
SCHEMBL31466795 0.75 GRM5 (0.68) GRM5PTGDR2KCNH2ADRB3TSPO
SCHEMBL610047 0.67 GRM5 (0.68) GRM5KCNH2ADRB3TSPOTMEM97
SCHEMBL27916910 0.64 GRM5 (0.45) GRM5KCNH2ADRB3TSPOTMEM97
SCHEMBL608301 0.64 GRM5 (0.70) GRM5KCNH2ADRB3TSPOTMEM97
SCHEMBL609825 0.63 GRM5 (0.75) GRM5KCNH2ADRB3TSPOTMEM97
SCHEMBL609274 0.63 GRM5 (0.75) GRM5KCNH2ADRB3TSPOTMEM97

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8293916-B2 Diazole derivatives HOFFMANN-LA ROCHE INC. (US) 2012-10-23 US disclosed
US-20100048569-A1 DIAZOLE DERIVATIVES BUETTELMANN BERND 2010-02-25 US disclosed
EP-1756086-B1 PYRIDIN-4-YL-ETHYNYL-IMIDAZOLES AND PYRAZOLES AS MGLU5 RECEPTOR ANTAGONISTS HOFFMANN LA ROCHE (CH) 2008-06-04 EP disclosed
US-20060030559-A1 Diazole derivatives F. HOFFMANN-LA ROCHE AG (CH) 2006-02-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100048569-A1 DIAZOLE DERIVATIVES GRM1, GRM2, GRIN2B GRM5 14/4885PTGDR2 533/4885KCNH2 551/4885
US-20060030559-A1 Diazole derivatives GRM1, GRM2, GRIN2B GRM5 14/4885PTGDR2 533/4885KCNH2 551/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.